|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +0.21% |
|
-8.82% | -28.74% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.42x | - | 13.83x | 74.93M | ||
| -.--% | -.--% | -139.71x | 17.73x | 11.48x | -158.84x | -127.82x | 33.14B | ||
| 1.14% | 1.15% | 17.77x | 2.23x | 1.74x | 10.03x | 12.09x | 20.98B | ||
| 5.41% | 5.47% | 16.09x | 1.14x | 1.28x | 7.26x | 13.26x | 6.95B | ||
| 0.86% | 1.1% | 53.92x | 11.11x | 9.52x | 33.43x | 42.32x | 2.9B | ||
| 1.6% | 2.1% | 33.69x | 1.64x | 1.47x | 11.96x | 20.41x | 1.68B | ||
| 0.88% | 1.05% | 28.61x | 1.7x | 1.15x | 9.52x | 13.45x | 1.65B | ||
| 6.44% | 8.02% | 11.74x | 1.57x | 1.25x | 4.87x | 8.34x | 1.58B | ||
| 0.12% | 0.12% | 81.93x | 14.72x | 17.06x | 42.12x | 57.43x | 1.49B | ||
| -.--% | -.--% | -24.97x | - | - | - | - | 1.45B | ||
| 0.37% | 0.43% | 57.26x | 7.89x | 6.85x | 28.28x | 40.88x | 1.21B | ||
| 3.99% | 3.99% | 30.5x | 1.28x | 0.76x | 6.3x | 21.56x | 1.08B | ||
| 1.99% | 2.3% | 43.79x | 13.45x | - | - | - | 911M | ||
| 3.38% | 3.8% | 18.1x | 1.05x | - | - | - | 825M | ||
| 0.4% | 0.48% | 24.25x | 1.82x | - | - | - | 747M | ||
| 4.11% | 4.82% | 27.5x | 1.07x | 1.28x | 6.02x | 10.64x | 517M | ||
| Average | 2.05% | 2.32% | 18.70x | 5.60x | 4.60x | 0.09x | 10.53x | 4.82B | |
| Weighted average by Cap. | 1.17% | 1.25% | -46.58x | 9.65x | 6.76x | -65.00x | -48.24x |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















